These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 15243112)

  • 21. Pneumolysin as a vaccine and drug target in the prevention and treatment of invasive pneumococcal disease.
    Cockeran R; Anderson R; Feldman C
    Arch Immunol Ther Exp (Warsz); 2005; 53(3):189-98. PubMed ID: 15995579
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sequence variation in the Streptococcus pneumoniae pneumolysin gene affecting haemolytic activity and electrophoretic mobility of the toxin.
    Lock RA; Zhang QY; Berry AM; Paton JC
    Microb Pathog; 1996 Aug; 21(2):71-83. PubMed ID: 8844651
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Priming and elongation: dissection of the lipoteichoic acid biosynthetic pathway in Gram-positive bacteria.
    Sutcliffe IC
    Mol Microbiol; 2011 Feb; 79(3):553-6. PubMed ID: 21255102
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lipoteichoic acid of Streptococcus oralis Uo5: a novel biochemical structure comprising an unusual phosphorylcholine substitution pattern compared to Streptococcus pneumoniae.
    Gisch N; Schwudke D; Thomsen S; Heß N; Hakenbeck R; Denapaite D
    Sci Rep; 2015 Nov; 5():16718. PubMed ID: 26577602
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Streptococcus pyogenes clinical isolates and lipoteichoic acid.
    Leon O; Panos C
    Infect Immun; 1990 Nov; 58(11):3779-87. PubMed ID: 2228247
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Streptolysin S activation by lipoteichoic acid.
    Theodore TS; Calandra GB
    Infect Immun; 1981 Jul; 33(1):326-8. PubMed ID: 7021426
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of the effects of macrolides, amoxicillin, ceftriaxone, doxycycline, tobramycin and fluoroquinolones, on the production of pneumolysin by Streptococcus pneumoniae in vitro.
    Anderson R; Steel HC; Cockeran R; von Gottberg A; de Gouveia L; Klugman KP; Mitchell TJ; Feldman C
    J Antimicrob Chemother; 2007 Nov; 60(5):1155-8. PubMed ID: 17848373
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tex, a putative transcriptional accessory factor, is involved in pathogen fitness in Streptococcus pneumoniae.
    He X; Thornton J; Carmicle-Davis S; McDaniel LS
    Microb Pathog; 2006 Dec; 41(6):199-206. PubMed ID: 16997528
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Occurrence of lipoteichoic acid in oral streptococci.
    Hogg SD; Whiley RA; De Soet JJ
    Int J Syst Bacteriol; 1997 Jan; 47(1):62-6. PubMed ID: 8995803
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pneumolysin is a key factor in misidentification of macrolide-resistant Streptococcus pneumoniae and is a putative virulence factor of S. mitis and other streptococci.
    Neeleman C; Klaassen CH; Klomberg DM; de Valk HA; Mouton JW
    J Clin Microbiol; 2004 Sep; 42(9):4355-7. PubMed ID: 15365043
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of cigarette smoke condensate on pneumococcal biofilm formation and pneumolysin.
    Mutepe ND; Cockeran R; Steel HC; Theron AJ; Mitchell TJ; Feldman C; Anderson R
    Eur Respir J; 2013 Feb; 41(2):392-5. PubMed ID: 22743667
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Capsule does not block antibody binding to PspA, a surface virulence protein of Streptococcus pneumoniae.
    Daniels CC; Briles TC; Mirza S; Håkansson AP; Briles DE
    Microb Pathog; 2006 May; 40(5):228-33. PubMed ID: 16540281
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lipoteichoic acid deficiency permits normal growth but impairs virulence of Streptococcus pneumoniae.
    Heß N; Waldow F; Kohler TP; Rohde M; Kreikemeyer B; Gómez-Mejia A; Hain T; Schwudke D; Vollmer W; Hammerschmidt S; Gisch N
    Nat Commun; 2017 Dec; 8(1):2093. PubMed ID: 29233962
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transcriptional regulation of TacL-mediated lipoteichoic acids biosynthesis by ComE during competence impacts pneumococcal transformation.
    Yao M; Wang K; Song G; Hu Y; Chen J; Li T; Liang L; Wu J; Xu H; Wang L; Zheng Y; Zhang X; Yin Y; Yao S; Wu K
    Front Cell Infect Microbiol; 2024; 14():1375312. PubMed ID: 38779562
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The wall associated lipoteichoic acid of Streptococcus sanguis.
    Hogg SD; Old LA
    Antonie Van Leeuwenhoek; 1993 Jan; 63(1):29-34. PubMed ID: 8386915
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Determination of viridans streptococci surface lipoteichoic acid by enzyme linked immune sorbent assay.
    Hogg SD; Manning JE
    FEMS Microbiol Lett; 1989 Apr; 49(2-3):239-42. PubMed ID: 2744420
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical outcome in pneumococcal meningitis correlates with CSF lipoteichoic acid concentrations.
    Schneider O; Michel U; Zysk G; Dubuis O; Nau R
    Neurology; 1999 Oct; 53(7):1584-7. PubMed ID: 10534274
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Structure and glycosylation of lipoteichoic acids in Bacillus strains.
    Iwasaki H; Shimada A; Yokoyama K; Ito E
    J Bacteriol; 1989 Jan; 171(1):424-9. PubMed ID: 2914853
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A new model of pneumococcal lipoteichoic acid structure resolves biochemical, biosynthetic, and serologic inconsistencies of the current model.
    Seo HS; Cartee RT; Pritchard DG; Nahm MH
    J Bacteriol; 2008 Apr; 190(7):2379-87. PubMed ID: 18245291
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of growth conditions on the formation of extracellular lipoteichoic acid by Streptococcus mutans BHT.
    Jacques NA; Hardy L; Knox KW; Wicken AJ
    Infect Immun; 1979 Jul; 25(1):75-84. PubMed ID: 39035
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.